{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T08:13:52Z","timestamp":1771920832440,"version":"3.50.1"},"reference-count":40,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,8]],"date-time":"2024-02-08T00:00:00Z","timestamp":1707350400000},"content-version":"vor","delay-in-days":3235,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jvsvenous.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Vascular Surgery: Venous and Lymphatic Disorders"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1016\/j.jvsv.2015.01.001","type":"journal-article","created":{"date-parts":[[2015,3,13]],"date-time":"2015-03-13T02:15:16Z","timestamp":1426212916000},"page":"228-235","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Thrombophilia testing has limited usefulness in clinical decision-making and should be used selectively"],"prefix":"10.1016","volume":"3","author":[{"given":"Elna M.","family":"Masuda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raymond W.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ian J.","family":"Okazaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pouya","family":"Benyamini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert L.","family":"Kistner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jvsv.2015.01.001_bib1","doi-asserted-by":"crossref","first-page":"367","DOI":"10.7326\/0003-4819-135-5-200109040-00013","article-title":"The thrombophilias: well-defined risk factors with uncertain therapeutic implications","volume":"135","author":"Bauer","year":"2001","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jvsv.2015.01.001_bib2","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1182\/asheducation-2011.1.150","article-title":"Is thrombophilia testing useful?","volume":"2011","author":"Middeldorp","year":"2011","journal-title":"Hematology Am Soc Hematol Edu Program"},{"key":"10.1016\/j.jvsv.2015.01.001_bib3","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1001\/archinte.166.7.729","article-title":"Risk of recurrent venous thromboembolism in patients with common thrombophilia: a systematic review","volume":"166","author":"Ho","year":"2006","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jvsv.2015.01.001_bib4","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1182\/asheducation-2013.1.9","article-title":"The ASH choosing wisely campaign: five hematologic tests and treatments to question","volume":"2013","author":"Hicks","year":"2013","journal-title":"Hematology"},{"key":"10.1016\/j.jvsv.2015.01.001_bib5","doi-asserted-by":"crossref","first-page":"138","DOI":"10.52964\/AMJA.0562","article-title":"The management of venous thromboembolic diseases and the role of thrombophilia testing: summary of NICE Guideline CG144","volume":"11","author":"Langford","year":"2012","journal-title":"Acute Med"},{"key":"10.1016\/j.jvsv.2015.01.001_bib6","unstructured":"ABIM Foundation\/Society for Vascular Medicine. Choosing wisely [released February 21, 2013]. Available at: http:\/\/www.choosingwisely.org\/doctor-patient-lists\/society-for-vascular-medicine. Accessed June 2014."},{"issue":"Suppl","key":"10.1016\/j.jvsv.2015.01.001_bib7","doi-asserted-by":"crossref","first-page":"e419S","DOI":"10.1378\/chest.11-2301","article-title":"Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines","volume":"141","author":"Kearon","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.jvsv.2015.01.001_bib8","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1191\/1358863x03vm461ra","article-title":"Hypercoagulable state testing and malignancy screening following venous thromboembolic events","volume":"8","author":"Deitcher","year":"2003","journal-title":"Vasc Med"},{"key":"10.1016\/j.jvsv.2015.01.001_bib9","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1182\/blood-2006-04-014654","article-title":"Homocysteine lowering by B vitamins and the secondary prevention of deep vein thrombosis and pulmonary embolism: a randomized placebo-controlled double-blind trial","volume":"109","author":"den Heijer","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.jvsv.2015.01.001_bib10","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s00277-008-0626-1","article-title":"Six versus 30 months anticoagulation for recurrent venous thrombosis in patients with high factor VIII","volume":"88","author":"Eischer","year":"2009","journal-title":"Ann Hematol"},{"key":"10.1016\/j.jvsv.2015.01.001_bib11","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1046\/j.1538-7836.2004.00698.x","article-title":"Comparison of 1 month with 3 months of anticoagulation for a first episode of venous thromboembolism associated with a transient risk factor","volume":"2","author":"Kearon","year":"2004","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jvsv.2015.01.001_bib12","doi-asserted-by":"crossref","first-page":"3484","DOI":"10.1182\/blood-2002-01-0108","article-title":"Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis","volume":"100","author":"Prandoni","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.jvsv.2015.01.001_bib13","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1002\/cncr.23814","article-title":"Anticoagulation for the initial treatment of venous thromboembolism in patients with cancer: a systematic review","volume":"113","author":"Akl","year":"2008","journal-title":"Cancer"},{"key":"10.1016\/j.jvsv.2015.01.001_bib14","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1161\/01.ATV.19.3.511","article-title":"Single and combined prothrombotic factors in patients with idiopathic venous thromboembolism: prevalence and risk assessment","volume":"19","author":"Salomon","year":"1999","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jvsv.2015.01.001_bib15","doi-asserted-by":"crossref","first-page":"2352","DOI":"10.1001\/jama.293.19.2352","article-title":"Thrombophilia, clinical factors, and recurrent venous thrombotic events","volume":"293","author":"Christiansen","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.jvsv.2015.01.001_bib16","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/S0140-6736(03)14111-6","article-title":"Incidence of recurrent venous thromboembolism in relation to clinical and thrombophilic risk factors: prospective cohort study","volume":"363","author":"Baglin","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.jvsv.2015.01.001_bib17","first-page":"695","article-title":"The risk of recurrent venous thromboembolism in patients with inherited deficiency of natural anticoagulants antithrombin, protein C and protein S","volume":"91","author":"De Stefano","year":"2006","journal-title":"Haematologica"},{"key":"10.1016\/j.jvsv.2015.01.001_bib18","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1111\/j.1538-7836.2008.03055.x","article-title":"Testing for inherited thrombophilia does not reduce the recurrence of venous thrombosis","volume":"6","author":"Coppens","year":"2008","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jvsv.2015.01.001_bib19","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1111\/j.1538-7836.2007.02658.x","article-title":"Current practice of testing for inherited thrombophilia","volume":"5","author":"Coppens","year":"2007","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jvsv.2015.01.001_bib20","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1056\/NEJM199702063360601","article-title":"The duration of oral anticoagulant therapy after a second episode of venous thromboembolism","volume":"336","author":"Schulman","year":"1997","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jvsv.2015.01.001_bib21","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","article-title":"International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)","volume":"4","author":"Miyakis","year":"2006","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jvsv.2015.01.001_bib22","first-page":"1","article-title":"An approach to differential diagnosis of antiphospholipid antibody syndrome and related conditions","volume":"2014","author":"Emmi","year":"2014","journal-title":"ScientificWorldJournal"},{"key":"10.1016\/j.jvsv.2015.01.001_bib23","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/S0002-9343(98)00060-6","article-title":"Anticardiolipin antibodies predict early recurrence of thromboembolism and death among patients with venous thromboembolism following anticoagulant therapy","volume":"104","author":"Schulman","year":"1998","journal-title":"Am J Med"},{"key":"10.1016\/j.jvsv.2015.01.001_bib24","doi-asserted-by":"crossref","first-page":"3685","DOI":"10.1182\/blood.V86.10.3685.bloodjournal86103685","article-title":"Antiphospholipid antibodies and venous thromboembolism","volume":"86","author":"Ginsberg","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.jvsv.2015.01.001_bib25","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.1111\/j.1538-7836.2006.02139.x","article-title":"Family history and inherited thrombophilia","volume":"4","author":"Van Sluis","year":"2006","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jvsv.2015.01.001_bib26","doi-asserted-by":"crossref","first-page":"5314","DOI":"10.1182\/blood-2008-10-184879","article-title":"Selective testing for thrombophilia in patients with first venous thrombosis: results from a retrospective family cohort study on absolute thrombotic risk for currently known thrombophilic defects in 2479 relatives","volume":"113","author":"Lijfering","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.jvsv.2015.01.001_bib27","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/j.1365-2141.2009.08022.x","article-title":"Clinical guidelines for testing for heritable thrombophilia","volume":"149","author":"Baglin","year":"2010","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jvsv.2015.01.001_bib28","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1097\/01.AOG.0000433981.36184.4e","article-title":"ACOG Practice Bulletin No. 138: Inherited thrombophilias in pregnancy","volume":"122","year":"2013","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jvsv.2015.01.001_bib29","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1097\/AOG.0b013e3182310c4c","article-title":"Practice Bulletin No. 123: thromboembolism in pregnancy","volume":"118","author":"James","year":"2011","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jvsv.2015.01.001_bib30","doi-asserted-by":"crossref","first-page":"e691S","DOI":"10.1378\/chest.11-2300","article-title":"VTE, thrombophilia, antithrombotic therapy, and pregnancy","volume":"141","author":"Bates","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.jvsv.2015.01.001_bib31","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.ogc.2013.10.005","article-title":"Inherited thrombophilias and adverse pregnancy outcomes","volume":"41","author":"Davenport","year":"2014","journal-title":"Obstet Gynecol Clin North Am"},{"key":"10.1016\/j.jvsv.2015.01.001_bib32","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1136\/bmj.314.7076.253","article-title":"Randomized controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies)","volume":"314","author":"Rai","year":"1997","journal-title":"BMJ"},{"key":"10.1016\/j.jvsv.2015.01.001_bib33","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/S0140-6736(94)90286-0","article-title":"Increased risk of venous thrombosis in oral-contraceptive users who are carriers of factor V Leiden mutation","volume":"344","author":"Vandenbroucke","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.jvsv.2015.01.001_bib34","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s11239-011-0572-y","article-title":"Evidence-based approach to thrombophilia testing","volume":"31","author":"Middeldorp","year":"2011","journal-title":"J\u00a0Thromb Thrombolysis"},{"key":"10.1016\/j.jvsv.2015.01.001_bib35","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1160\/TH13-01-0011","article-title":"Testing for inherited thrombophilia and consequences for antithrombotic prophylaxis in patients with venous thromboembolism and their relatives","volume":"110","author":"De Stefano","year":"2013","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jvsv.2015.01.001_bib36","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/S0140-6736(03)14066-4","article-title":"Differential association of oral and transdermal oestrogen-replacement therapy with venous thromboembolism risk","volume":"362","author":"Scarabin","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.jvsv.2015.01.001_bib37","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1161\/CIRCULATIONAHA.106.642280","article-title":"Hormone therapy and venous thromboembolism among postmenopausal women: impact of the route of estrogen administration and progestogens: the ESTHER study","volume":"115","author":"Canonico","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.jvsv.2015.01.001_bib38","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1182\/blood.V75.1.33.33","article-title":"Evaluation of the safety, recovery, half-life, and clinical efficacy of antithrombin III (human) in patients with hereditary antithrombin III deficiency","volume":"75","author":"Menache","year":"1990","journal-title":"Blood"},{"key":"10.1016\/j.jvsv.2015.01.001_bib39","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1053\/j.semvascsurg.2010.05.006","article-title":"What is the optimal duration of treatment for DVT? An update on evidence-based medicine of treatment for DVT","volume":"23","author":"East","year":"2010","journal-title":"Semin Vasc Surg"},{"key":"10.1016\/j.jvsv.2015.01.001_bib40","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1136\/thoraxjnl-2012-202376","article-title":"NICE guidelines: management of venous thromboembolic disease and role of thrombophilia testing","volume":"68","author":"Howard","year":"2013","journal-title":"Thorax"}],"container-title":["Journal of Vascular Surgery: Venous and Lymphatic Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213333X15000086?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213333X15000086?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T06:58:53Z","timestamp":1761980333000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213333X15000086"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["S2213333X15000086"],"URL":"https:\/\/doi.org\/10.1016\/j.jvsv.2015.01.001","relation":{},"ISSN":["2213-333X"],"issn-type":[{"value":"2213-333X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Thrombophilia testing has limited usefulness in clinical decision-making and should be used selectively","name":"articletitle","label":"Article Title"},{"value":"Journal of Vascular Surgery: Venous and Lymphatic Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jvsv.2015.01.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Society for Vascular Surgery. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}